Effect of Ligustrazine on Atherosclerosis in Rabbits
|更新时间:2024-01-04
|
Effect of Ligustrazine on Atherosclerosis in Rabbits
Chinese Journal of Experimental Traditional Medical FormulaeVol. 18, Issue 14, Pages: 202-205(2012)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2012
稿件说明:
移动端阅览
WANG Guo-feng, LU Feng, ZHAO Xia, et al. Effect of Ligustrazine on Atherosclerosis in Rabbits[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(14): 202-205.
DOI:
WANG Guo-feng, LU Feng, ZHAO Xia, et al. Effect of Ligustrazine on Atherosclerosis in Rabbits[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(14): 202-205.DOI:
Effect of Ligustrazine on Atherosclerosis in Rabbits
Objective: To investigate the antiatherosclerotic efficacy by ligustrazine (LIG). Method: Twenty-four rabbits were randomly divided into four groups: normal control group
model control group
LIG (75 mg·kg-1) group and LIG (150 mg·kg-1) group. In in vivo experiments
rabbits fed by high cholesterol diet have been used to evaluate the antiatherosclerotic efficacy of LIG (75
150 mg·kg-1) including plaque surface area in aorta
intima/media (I/M) ratios
foam cell amounts
serum lipid level of tolal cholesterol(TC)
triglyceride(TG)
low density lipoprotein cholesterol(LDL-C) and high density lipoprotein cholesterol(HDL-C) after twelve weeks. Result: Comparied with model control group
LIG could reduce the plaque surface area in aorta at the dose of 75
150 mg·kg-1 (420.4±46.2) mm2 and (310.2±12.3) mm2 vs (663.2±38.9) mm2
P<0.01). I/M ratios and foam cell amounts were also decreased (P<0.01). Serum lipid level of TC
TG and LDL-C was depressed; however serum level of HDL-C had no changes. Conclusion: Antiatherosclerotic effects by LIG lie at endothelial cells.
Exploration of Zhuyuwan in Treatment of Atherosclerosis from Perspective of Lipid Transport Disorder
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Effect of Co-treatment Method of Stagnation of Phlegm and Blood Stasis (Danlou Tablet) on Vascular Endothelial Function in Patients with Atherosclerosis
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Analysis of Mechanism of Astragaloside Ⅳ in Regulating Ferroptosis Through SLC7A11/GPX4 Pathway Against Vascular Smooth Muscle Cell Proliferation
Related Author
SONG Wei
ZHANG Zhongyi
QIU Hairong
ZHAO Mei
ZHOU Zubing
SHEN Tao
ZHANG Yong
LIANG Yuqin
Related Institution
Chengdu University of Traditional Chinese Medicine(TCM)
Hospital of Chengdu University of TCM
Hubei Minzu University
Institute of TCM, Sichuan Academy of Chinese Medicine Sciences
Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine